| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/29/2013 | CN103124563A Combination therapy for the treatment of prostate carcinoma |
| 05/29/2013 | CN103124561A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
| 05/29/2013 | CN103124557A 纯埃罗替尼 Pure erlotinib |
| 05/29/2013 | CN103122318A Marine fungus penicillium citrinum and application thereof in preparing anti-tumor drugs |
| 05/29/2013 | CN103122004A Naphthoquinone compound with antitumor activity |
| 05/29/2013 | CN103122003A Naphthoquinone compound with antitumor activity |
| 05/29/2013 | CN103122002A Naphthoquinone compound with antitumor activity |
| 05/29/2013 | CN103122001A Polo-like kinase inhibitors |
| 05/29/2013 | CN103122000A High-selectivity c-Met kinase inhibitor used as antitumor drug |
| 05/29/2013 | CN103121996A Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors |
| 05/29/2013 | CN103121994A Salt of pyrrole derivative |
| 05/29/2013 | CN103121993A Salt of 2,6-dichloro-3-fluorophenyl derivative |
| 05/29/2013 | CN103121991A Aryl carboxylic acid imatinib derivative as well as preparation and application thereof |
| 05/29/2013 | CN103121990A Cinnamyl amide imatinib ramification as well as preparation method and application thereof |
| 05/29/2013 | CN103121973A Pyrimidine urea derivatives as kinase inhibitors |
| 05/29/2013 | CN103121972A Pyrimidine urea derivatives as kinase inhibitors |
| 05/29/2013 | CN103121971A Salt for aryl urea derivant |
| 05/29/2013 | CN103121968A Salt of quinoline derivative |
| 05/29/2013 | CN103121965A Salts of indolone derivatives |
| 05/29/2013 | CN103121705A Preparation method of CuS nanoparticles, product and application thereof |
| 05/29/2013 | CN103120798A Preparation method and application of phospholipid complex with anti-oxidative stress |
| 05/29/2013 | CN103120797A Nano-drug carrier for reductive response, nano-drug particle, nano-drug particle preparation and preparation methods thereof |
| 05/29/2013 | CN103120796A Antitumor compound of dichloroacetic acid connected with alkaline antitumor drug |
| 05/29/2013 | CN103120794A Pharmaceutic adjuvant with collaborative work and anti-tumor application thereof |
| 05/29/2013 | CN103120754A Leukemia preventing and treating tablet and preparation method thereof |
| 05/29/2013 | CN103120710A Fried semen lepidii antitumor active ingredient extract and preparation method and application thereof |
| 05/29/2013 | CN103120700A Method for preparing arisaema heterophyllum polysaccharide with anti-tumor activity |
| 05/29/2013 | CN103120697A Application of squamatic acid to preparation of antitumor drugs |
| 05/29/2013 | CN103120696A Application of baeomycesic acid to preparation of antitumor drugs |
| 05/29/2013 | CN103120684A Application of Aphanamixoid A in medicine for treating endometrial carcinoma |
| 05/29/2013 | CN103120682A Application of Aphanamixoid A in medicine for treating bladder cancer |
| 05/29/2013 | CN103120681A Application of Aphanamixoid A in medicine for resisting lung cancer metastasis |
| 05/29/2013 | CN103120680A Application of Aphanamixoid A in medicine for treating nasopharyngeal carcinoma |
| 05/29/2013 | CN103120679A Application of Aphanamixoid A in medicine for treating tongue cancer |
| 05/29/2013 | CN103120678A Application of Aphanamixoid A in medicine for treating liver cancer |
| 05/29/2013 | CN103120666A Application of Aphanamixoid A in medicine for treating human cervical carcinoma |
| 05/29/2013 | CN103120665A Application of Aphanamixoid A in medicine for treating prostatic cancer |
| 05/29/2013 | CN103120645A Irinotecan or irinotecan hydrochloride lipidosome and preparation method thereof |
| 05/29/2013 | CN103120643A Curcumin dicaprate suspension injection and preparation method and application thereof |
| 05/29/2013 | CN103120640A Embolic agent as well as preparation method and use method thereof |
| 05/29/2013 | CN102670656B Chinese medicinal enteric capsules for treating medium-term and advanced tumors and chronic hepatitis B and preparation method for capsules |
| 05/29/2013 | CN102558393B Preparation process of dalteparin sodium |
| 05/29/2013 | CN102552753B Chinese medicinal composition for treating uterine fibroid |
| 05/29/2013 | CN102552273B Composition containing epigallocatechin gallate and methotrexate |
| 05/29/2013 | CN102552244B Composition for inhibiting tumor cell proliferation by using epigallocatechin gallate and carboplatin |
| 05/29/2013 | CN102526543B Decoction for treating lung cancer |
| 05/29/2013 | CN102516388B Anthropogenic LMP1 (latent membrane protein1) extracellular regional antibody for nasopharyngeal carcinoma and application thereof |
| 05/29/2013 | CN102429900B Application of natural compound P25 in inhibiting reproduction and growth of tumour cells |
| 05/29/2013 | CN102429898B Application of natural compound P47 in inhibiting reproduction and growth of tumour cells |
| 05/29/2013 | CN102397287B Application of opuntia ficus-indica polysaccharide in preparation of medicine with hypolipidemic effect |
| 05/29/2013 | CN102397286B Application of prickly pear polysaccharide in preparation of medicament or health-care product with hypoglycemic effect |
| 05/29/2013 | CN102391263B Deuteroacetyl-containing kinase inhibitor |
| 05/29/2013 | CN102370987B Injection liposome entrapping antineoplastic pharmaceutical composition |
| 05/29/2013 | CN102366416B Pharmaceutical application of 12-dehydroxy-21-hydroxy protopanoxadiol |
| 05/29/2013 | CN102309493B Anti-cancer medicinal composition |
| 05/29/2013 | CN102250188B Ursolic acid series medicament with anti-inflammatory and anti-tumor activity and preparation thereof |
| 05/29/2013 | CN102206180B Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 05/29/2013 | CN102151336B Active targeting drug conveying system for crossing blood brain barrier through mediation of acetylcholine receptor |
| 05/29/2013 | CN102146056B N-benzyl-acridone, derivatives of N-benzyl-acridone and preparation methods and application of N-benzyl-acridone and derivatives |
| 05/29/2013 | CN102138957B Colocynth extract, and production method and application thereof |
| 05/29/2013 | CN102124100B A monoclonal antibody specifically binding to VEGF and the hybridoma secreting same and uses thereof |
| 05/29/2013 | CN102050733B Biphenyl cyclooctene type lignan compound and medicinal application thereof |
| 05/29/2013 | CN102038644B Lutein water-soluble powder and preparation process thereof |
| 05/29/2013 | CN101981013B Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors |
| 05/29/2013 | CN101978054B Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 05/29/2013 | CN101967127B Quinazoline derivative and preparation method thereof and application of quinazoline derivative for preparing anticancer drugs |
| 05/29/2013 | CN101891706B 3,4-dihydrobenzo[f][1,4]thiazepine compound or salts of same and medical use of same |
| 05/29/2013 | CN101883557B Novel thermosensitive liposomes containing therapeutic agents |
| 05/29/2013 | CN101830894B Benzo[d]oxazole compounds and preparation method thereof |
| 05/29/2013 | CN101812491B Method for producing pleurotus ferulae polysaccharide and oral liquid thereof through fermentation |
| 05/29/2013 | CN101805699B Method for preparing gliocladicillin C and application thereof |
| 05/29/2013 | CN101730701B Hydrated crystalline esters of camptothecin for the treatment of cancer |
| 05/29/2013 | CN101730533B Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt |
| 05/29/2013 | CN101669934B application of mango aglycone in preparing medicine for obesity |
| 05/29/2013 | CN101531644B New daphnane diterpene compounds in Daphne genkwa as well as preparation method and application of same |
| 05/29/2013 | CN101384575B Tiglien-3-one derivatives |
| 05/29/2013 | CN101370804B Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 05/29/2013 | CN101184734B Compound and methods of treating cell proliferation disorders |
| 05/28/2013 | US8450502 Pharmaceutical compositions for inhibiting angiogenesis |
| 05/28/2013 | US8450479 3-substituted-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5-tetrazine-8-carboxylic acid amides and their use |
| 05/28/2013 | US8450470 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments |
| 05/28/2013 | US8450334 Hepsin inhibitors |
| 05/28/2013 | US8450329 Benzoxazole kinase inhibitors and methods of use |
| 05/28/2013 | US8450310 Isoxazole compounds as inhibitors of heat shock proteins |
| 05/28/2013 | US8449890 Neprilysin inhibitors |
| 05/28/2013 | US8449889 Immuno-molecules containing viral proteins, compositions thereof and methods of using |
| 05/28/2013 | CA2720946C Compounds and compositions as protein kinase inhibitors |
| 05/28/2013 | CA2714295C Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/28/2013 | CA2672716C Novel therapeutic use for treating leukaemia |
| 05/28/2013 | CA2664113C Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
| 05/28/2013 | CA2584651C Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds |
| 05/28/2013 | CA2573092C Pyridodihydropyrazinones method for production and use thereof as medicaments |
| 05/28/2013 | CA2571293C 2-benzylaminodihydropteridinones, method for producing them and use thereof as drugs |
| 05/28/2013 | CA2564592C Compositions for improving breast health in women |
| 05/28/2013 | CA2562693C Reverse-turn mimetics and method relating thereto |
| 05/28/2013 | CA2550298C Reduction of toxicity of multi-targeting antifolates |
| 05/28/2013 | CA2550222C Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases |
| 05/28/2013 | CA2521649C Composition and uses of galectin antagonists |
| 05/28/2013 | CA2506581C Novel 2',5'-oligoadenylic acid analogues |
| 05/28/2013 | CA2485346C Human adam-10 inhibitors |